This page provides access to Magnera Corporation’s (NYSE: MAGN) SEC filings, offering a structured view of the company’s regulatory disclosures. Magnera is a Pennsylvania‑incorporated specialty materials company listed on the New York Stock Exchange under the symbol MAGN, serving more than 1,000 customers worldwide with components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products for the food and beverage industry.
Through its filings with the U.S. Securities and Exchange Commission, Magnera reports information about its financial condition, results of operations, governance, and executive compensation. Annual reports on Form 10‑K and quarterly reports on Form 10‑Q detail segment performance for the Americas and Rest of World, cash flow from operating activities, capital expenditures, property, plant and equipment, goodwill and intangible assets, and non‑GAAP metrics such as adjusted EBITDA and free cash flow, along with reconciliations.
Current reports on Form 8‑K disclose material events, including quarterly and annual earnings releases, guidance updates, officer departures, and information about the timing of the annual meeting of shareholders. These filings also confirm Magnera’s exchange listing, state of incorporation, and other key registrant details. Definitive proxy statements on Schedule 14A describe board composition, committee structure, corporate governance practices, and the design of executive compensation programs, including pay‑for‑performance elements and stock ownership guidelines.
On Stock Titan, AI‑powered tools summarize lengthy filings so readers can quickly identify major topics such as changes in leverage, cash flow trends, Project CORE transformation activities, and items related to director elections or say‑on‑pay proposals. Users can review real‑time updates as new documents are posted to EDGAR, including Forms 10‑K, 10‑Q, 8‑K, and proxy statements, and use the summaries to focus on sections most relevant to their analysis of MAGN.
Magnera Corp director Bruce Brown reported a corrected purchase of 4,235 shares of common stock on May 29, 2025, at $11.8054 per share. His reported holdings following the purchase were 16,555 shares. No Rule 10b5-1 plan is reported.
Magnera Corp received an updated Schedule 13G/A reporting that institutional holder Morgan Stanley, together with Morgan Stanley Capital Services LLC, now beneficially owns less than 5% of Magnera’s common stock. Morgan Stanley reports shared voting power over 1,388,482 shares and shared dispositive power over 1,391,243 shares3.9% of the common stock. Morgan Stanley Capital Services LLC separately reports shared voting and dispositive power over 1,369,957 shares, representing 3.8% of the class. Both entities state that, as of the reporting date, they have ceased to be beneficial owners of more than five percent of Magnera’s common stock.
Magnera Corporation reported net sales of $857 million for the quarter ended June 27, 2026, up 2% from $839 million, and a net loss of $20 million, or $0.56 per share. For the first three quarters, net sales were $2,445 million and net loss $72 million, or $2.01 per share, compared with $2,365 million and $119 million a year earlier. Operating income improved to $22 million for the quarter and $53 million year-to-date, versus $13 million and a $5 million loss, driven by a stronger price-cost spread, lower depreciation and amortization, and merger-related benefits, partly offset by higher integration and SG&A costs.
Adjusted EBITDA was $99 million in the quarter and $282 million year-to-date, led by the Americas segment with $71 million for the quarter and $187 million year-to-date, while Rest of World contributed $28 million and $95 million. Net cash from operating activities reached $76 million year-to-date, translating into free cash flow of $32 million after $44 million of capital expenditures. Cash and cash equivalents were $280 million and long-term debt $1.90 billion, with no borrowings under the $350 million revolving credit facility.
Management projects fiscal 2026 cash from operations of $150–$170 million and free cash flow of $90–$110 million, assuming $60 million of capital spending. The Project CORE restructuring and integration of the November 2024 business combination continue, with $61 million of year-to-date restructuring and related charges. Management again concluded that disclosure controls and procedures were not effective as of June 27, 2026 due to merger-related and IT control deficiencies, though no material misstatements were identified.
Magnera Corporation reported third quarter 2026 results with net sales of $857 million, up 2% from the prior-year quarter, and adjusted EBITDA of $99 million, 9% higher. The company recorded a net loss of $20 million, or $0.56 per share, compared with a loss of $18 million a year earlier.
The net sales increase included a favorable foreign currency impact of $21 million and a 1% organic volume improvement, partly offset by an $8 million decrease in selling prices driven by product mix and raw material pass-through. In the Americas, net sales benefited from $10 million of positive currency and 1% volume growth, while an $11 million favorable price-cost spread, supported by Project CORE and merger synergies, lifted adjusted EBITDA. In the Rest of World segment, higher prices and $11 million favorable currency were offset by inflation, timing of material pass-throughs and higher selling, general and administrative costs, leading to a modest adjusted EBITDA decline.
For the first three quarters of 2026, net sales were $2,445 million and adjusted EBITDA was $282 million, compared with $2,365 million and $264 million in 2025, with a net loss of $72 million versus $119 million. Net cash from operating activities was $76 million, producing free cash flow of $32 million after $44 million of capital spending. At June 27, 2026, Magnera held $280 million of cash, $1,901 million of debt and $1,017 million of stockholders’ equity.
Cetus Capital VI, L.P., a Delaware limited partnership, reports its beneficial ownership of common stock of Magnera Corp. Cetus holds 1,561,199 shares of Magnera common stock, representing 4.36% of the class, based on 35.8 million shares outstanding as of May 7, 2026.
Cetus has sole voting and dispositive power over all 1,561,199 shares and no shared voting or dispositive power. The filing notes that the position represents ownership of 5 percent or less of the class, and identifies Littlejohn Associates VI, L.P. as Cetus’s general partner.
Newtyn Management, LLC reports beneficial ownership of 2,760,000 shares (7.7%) of Magnera Corporation. As of March 31, 2026, the Reporting Person may be deemed to beneficially own the aggregate holdings of two managed partnerships: Newtyn TE Partners, LP with 1,757,147 shares and Newtyn Partners, LP with 1,002,853 shares. The filing cites approximately 35.9 million shares outstanding as of February 5, 2026 as the basis for the percentage.
Magnera Corporation common stock ownership update: a group led by Madison Avenue International LP reports beneficial ownership of 1,590,616 shares as of March 31, 2026. The filing states this represents approximately 4.4% of the company based on 35,900,000 shares outstanding as of February 5, 2026. The statement identifies related entities and individuals (Madison Avenue Partners, EMAI Management, Madison Avenue GP, Caraway Jackson Investments LLC, and Eli Samaha) that may be deemed beneficial owners through managerial or ownership relationships.
Morgan Stanley files an amendment reporting beneficial ownership in Magnera Corp Common Stock. The filing shows 1,892,151 shares reported for Morgan Stanley (representing 5.3%) and 1,875,207 shares for Morgan Stanley Capital Services LLC (representing 5.2%), as provided on the cover pages. The filing is signed by an authorized signatory on 05/12/2026.
Magnera Corp ownership update: Cetus Capital VI, L.P. reports beneficial ownership of 2,242,705 shares of Magnera Corp common stock, representing 6.26% of the class. The filing cites 35.8 million shares outstanding as of May 7, 2026 as the basis for the percentage. The Schedule 13G/A is signed by Littlejohn Associates VI, L.P. as general partner, dated 05/11/2026.
Magnera Corporation reported a smaller loss and stronger cash flow for the quarter ended March 28, 2026. Net sales were $796 million, down 3% from $824 million a year ago, as lower selling prices and modest volume declines offset favorable currency.
Net loss narrowed to $18 million from $41 million, with operating income improving to $17 million from $4 million helped by lower restructuring, depreciation and amortization. Year‑to‑date net loss was $52 million on net sales of $1.588 billion.
Cash from operating activities rose sharply to $89 million year‑to‑date from $7 million, yielding free cash flow of $60 million. Magnera held $303 million of cash and $1.899 billion of long‑term debt, and projects fiscal 2026 cash from operations of $170–$190 million and free cash flow of $90–$110 million. The Project CORE restructuring continued, and management again concluded its disclosure controls and procedures were not effective as merger‑related and IT control remediation remains in progress.